Rethinking tendinopathy treatments

By Jennie McKee

New treatment strategies—such as using MMP inhibitors—may enhance care

“Conventional thinking says that tendinopathy—defined as chronic tendon degeneration—is due to tendon overload, leading to microscopic collagen fiber failure and a failed healing response,” said Scott A. Rodeo, MD, during the 2011 American Orthopaedic Society for Sports Medicine Specialty Day program. “It also says that inflammation is not part of the pathologic process, because inflammatory cells are not seen in biopsies obtained at the time of surgery in patients with tendinosis.”

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!